✦ LIBER ✦

PW01-193 - Safety and efficacy of long-term asenapine versus olanzapine in schizophrenia or schizoaffective disorder patients

✍ Scribed by Schoemaker, J.; Naber, D.; Jansen, W.; Panagides, J.; Emsley, R.

Book ID: 121918969
Publisher: Elsevier Science
Year: 2010
Tongue: French
Weight: 33 KB
Volume: 25
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(10)71600-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of aripipr

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

✍ Jun Soo Kwon; Joon Hwan Jang; Do-Hyung Kang; So Young Yoo; Yong Ku Kim; Seong-Ji 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Long-term safety and tolerability of lon

Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder

✍ Jean-Pierre Lindenmayer; Akbar Khan; Mariëlle Eerdekens; Ilse Van Hove; Stuart K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

P.3.c.006 Safety and efficacy of olanzap

P.3.c.006 Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder

✍ D.P. McDonnell; H.C. Detke; M. Choukour; J. Landry 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Outcomes and Costs of Risperidone versus

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

✍ Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia Rupnow; Amy Grog 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Long term efficacy and safety of olanzap

Long term efficacy and safety of olanzapine in patients with inadequate initial response to haloperidol or olanzapine

✍ C. Mallinckrodt; S. David; P. Burns; A. Breier 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 180 KB